Menu
Recruiting NCT05971719

Validation of a System Using Aerosol Glycerine to Detect and Localize Intraoperatively Pulmonary Air Leaks

No phase Interventional Air Leak From Lung

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Air Leaks: Aerosol glycerine System.
Who it may be relevant to
Registry conditions: Air Leak From Lung. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Air leaks represent one of the most common complications and postoperative morbidity in thoracic surgery. Air leaks have been associated with the largest preventable morbidity associated with increased costs following lobectomy (typically related to increased length of stay). However, the standard used to detect and localize the air leaks, the submersion test, is not suitable for the standard surgical procedure, Video Assisted Thoracic Surgery. Considering the prevalence of this complication and the absence of a surgical standard of care for such complications, the aim of this study is to develop a system to create and send a glycerine aerosol smoke in the lungs of the patient. The smoke is visible with standard laparoscope and will flow though the pulmonary leak, thereby reducing postoperative surgical complications, morbidity, and length of stay for patients undergoing pulmonary resection.

Interventions

  • Diagnostic test Air Leaks: Aerosol glycerine System
    A range of different leak will be done with different needle sizes on the lung. Perform localization on staple lines used surgically during pulmonary surgeries, as they are known to not consistently give an airtight closure. The lung will be put in the ex-vivo model and ask for a surgeon to localize the leaks with our system. The needle incisions will be repeat on another lung and ask the same surgeon to localize the leaks with the submersion test. To perform the submersion test the surgeon will

Primary outcome measures

  • Localization efficacy [Time frame: 48 months]
Secondary outcome measures (3)
  • Duration of localization [Time frame: 48 months]
  • Minimal leak localizable [Time frame: 48 months]
  • Staple lines airtightness [Time frame: 48 months]

Eligibility criteria

Inclusion criteria

  • Patients undergoing lung transplant surgery
  • Organ donor ineligible to donate lungs

Exclusion criteria

  • Healthy individuals

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

Canada · 1 center
  • CHUM — Montreal

Identifiers

NCT: NCT05971719 · 2024-11574

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗